CIDRAP newsletters options
In other developments, only 1 new Ebola case has been reported in recent days.
In updates yesterday and today, Saudi Arabia's Ministry of Health (MOH) reported two more MERS-CoV cases, one of them fatal and both from Riyadh.
One of the patients is a 33-year-old man whose contact with camels isn't known. He is not a health worker, and his exposure is listed as primary, meaning he probably didn't contract MERS-CoV (Middle East respiratory syndrome coronavirus) from another patient.
A retrospective analysis of Veterans Administration (VA) patients who had stool testing for Clostridiodes difficile shows an overall decrease in C difficile infection (CDI) over the course of a decade, with temporal increases linked to implementation of molecular testing methods, researchers reported today in Infection Control and Hospital Epidemiology.
Some parts of the south and central US are among the few hot spots, and flu strains vary by region.
The US Agency for International Development (USAID) today announced an additional $56 million in humanitarian aid to help curb the Democratic Republic of Congo (DRC) Ebola outbreak.
According to a statement, the new funding brings USAID's total since the August 2018 start of the outbreak to $266 million. The support also targets preparedness efforts in the region and in countries that neighbor the DRC.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Nearly one in five antibiotic prescriptions for hospitalized children in Australia is inappropriate, Australian researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.
With 1 new case today, the outbreak total climbs to 3,286, and recent cases reflect movement of infected people.
Takeda's dengue vaccine candidate (TAK-003) is safe and effective against dengue virus, according to part 1 of phase 3 clinical trial results published yesterday in the New England Journal of Medicine.
Also, a study today highlights serious long-term symptoms among Ebola survivors.
Coincidentally, all 3 new Saudi cases involved camel contact.
The results of a randomized clinical trial show that the use of a rapid, multi-pathogen respiratory panel (RP) in an emergency department (ED) was associated with a trend toward decreased antibiotic use, according to a study yesterday in Open Forum Infectious Diseases.
Researchers studying the incidence of respiratory syncytial virus (RSV) deaths in India's Maharashtra state earlier this year identified an H9N2 avian flu infection in a 17-month-old boy, according to a study published today in Emerging Infectious Diseases.
Poll finds 41% expect antibiotics if they have a cold that lingers.
After going 2 days with no new cases, the Democratic Republic of the Congo (DRC) today reported 7 new lab-confirmed cases and 1 additional probable infection, raising the overall outbreak total to 3,282, which includes 118 probable cases, according to the World Health Organization (WHO) online Ebola dashboard.
Health officials are still investigating 447 suspected Ebola cases.
Fecal microbiota transplant (FMT) for Clostridioides difficile infection (CDI) was associated with a dramatic decrease in bloodstream infections (BSIs), days of hospitalization, and death rates compared to treatment with antibiotics, according to a prospective cohort study today in the Annals of Internal Medicine.
The proportion of candidemia in patients with injection drug use more than doubled.
11,000 doses of Johnson & Johnson's Ebola vaccine arrived in the DRC over the weekend.
About 61,000 antibiotic-resistant infections occurred in England last year, up 9%.
Saudi Arabia yesterday reported another lab-confirmed MERS-CoV infection, the second so far for November.
